MedicalSystem Biotechnology Co., Ltd. (300439) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MedicalSystem Biotechnology Co., Ltd.

Why is MedicalSystem Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -8.42% and Operating profit at -159.22% over the last 5 years

The company has declared Negative results for the last 6 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 277.05 MM
NET PROFIT(HY) At CNY 36.22 MM has Grown at -43.2%
INTEREST(HY) At CNY 1.57 MM has Grown at 13.44%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -17.34% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedicalSystem Biotechnology Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

MedicalSystem Biotechnology Co., Ltd.

-100.0%

-0.42

24.05%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-8.42%

EBIT Growth (5y)

-159.22%

EBIT to Interest (avg)

24.44

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.25

Sales to Capital Employed (avg)

0.57

Tax Ratio

6.81%

Dividend Payout Ratio

20.02%

Pledged Shares

Institutional Holding

ROCE (avg)

9.78%

ROE (avg)

8.27%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.69

EV to EBIT

-70.38

EV to EBITDA

10.94

EV to Capital Employed

0.58

EV to Sales

0.82

PEG Ratio

Dividend Yield

2.50%

ROCE (Latest)

-0.82%

ROE (Latest)

2.15%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -10.31% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 36.53 MM

NET PROFIT(Q)

Highest at CNY 33.09 MM

EPS(Q)

Highest at CNY 0.09

-19What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 277.05 MM

NET PROFIT(HY)

At CNY 36.22 MM has Grown at -43.2%

INTEREST(HY)

At CNY 1.57 MM has Grown at 13.44%

ROCE(HY)

Lowest at 2.23%

Here's what is working for MedicalSystem Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 36.53 MM has Grown at 244.41%

over average net sales of the previous four periods of CNY 10.61 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 36.53 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 33.09 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 33.09 MM has Grown at 110.66%

over average net sales of the previous four periods of CNY 15.71 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.09

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -10.31% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MedicalSystem Biotechnology Co., Ltd.

Interest

At CNY 1.57 MM has Grown at 13.44%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 277.05 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)